Is retinal arteriolar–venular ratio associated with cardiac and extracardiac organ damage in essential hypertension?

Aim Whether retinal microvascular disease is associated with markers of cardiac and extracardiac organ damage in human hypertension is still unclear. We examined the relationship between retinal arteriolar–venular ratio (AVR) and left ventricular hypertrophy, carotid atherosclerosis and microalbuminuria in essential hypertension. Methods A total of 386 untreated and treated uncomplicated essential hypertensive individuals (mean age 56 ± 13 years) consecutively attending our hospital outpatient hypertension clinic were considered for the analysis. All individuals underwent extensive clinical and laboratory investigations, including retinal AVR evaluation by a fully automated computer-assisted method, echocardiography and carotid ultrasonography. Results Mean retinal AVR was 0.790 ± 0.079 (range 0.530–0.990). In univariate analyses, AVR showed a significant inverse association with left ventricular mass index (r = −0.15, P = 0.002) and carotid intima–media thickness (IMT) (r = –0.12, P = 0.02); no relationship with microalbuminuria was found. Overall, left ventricular mass index and carotid IMT as well as microalbuminuria, either as continuous or categorical variables, did not show significant differences across AVR quartiles. Moreover, a multivariate analysis failed to demonstrate independent correlations of carotid IMT and left ventricular mass index (P = 0.06 for both) with AVR. Finally, when patients were categorized according to the presence or absence of organ damage, with or without left ventricular hypertrophy (0.783 ± 0.077 vs. 0.795 ± 0.081), carotid plaques (0.789 ± 0.079 vs. 0.791 ± 0.079), carotid IMT (0.791 ± 0.077 vs. 0.788 ± 0.082) or microalbuminuria (0.791 ± 0.080 vs. 0.777 ± 0.073), no significant intergroup differences in AVR values were found. Conclusion Our findings provide further evidence that retinal AVR is of limited value in identifying hypertensive patients at high cardiovascular risk related to cardiac and extracardiac organ damage.

[1]  Albert Hofman,et al.  Retinal Vessel Diameters and Risk of Hypertension The Rotterdam Study , 2006 .

[2]  N Reichek,et al.  Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.

[3]  J. Laragh,et al.  Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. , 1995, Journal of the American College of Cardiology.

[4]  F. Magrini,et al.  Retinal microvascular changes and target organ damage in untreated essential hypertensives , 2004, Journal of hypertension.

[5]  R. Klein,et al.  Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study , 2001, The Lancet.

[6]  Tibbs Dj.  MANAGEMENT OF HAEMOPHILIA. , 1965, Lancet.

[7]  W. A. Littler,et al.  USEFULNESS OF OPHTHALMOSCOPY IN MILD TO MODERATE HYPERTENSION , 1989, The Lancet.

[8]  M. Mills,et al.  Quantitative analysis of retinal vessel diameter reduction after photocoagulation treatment for retinopathy of prematurity. , 2007, American journal of ophthalmology.

[9]  Tien Yin Wong,et al.  Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. , 2004, Investigative ophthalmology & visual science.

[10]  L. Bouter,et al.  Retinopathy is associated with cardiovascular and all-cause mortality in both diabetic and nondiabetic subjects: the hoorn study. , 2003, Diabetes care.

[11]  R. Klein,et al.  Racial Differences in the Prevalence of Hypertensive Retinopathy , 2003, Hypertension.

[12]  N. M. Keith,et al.  Some Different Types Of Essential Hypertension: Their Course And Prognosis , 1939, The American journal of the medical sciences.

[13]  J M Gibson,et al.  Hypertensive retinopathy: a review of existing classification systems and a suggestion for a simplified grading system. , 1996, Journal of human hypertension.

[14]  H. Matsuoka,et al.  Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension , 1995, Journal of hypertension.

[15]  F. Magrini,et al.  Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study , 2005, Blood pressure.

[16]  L. Bouter,et al.  Are retinal microvascular abnormalities associated with large artery endothelial dysfunction and intima-media thickness? The Hoorn Study. , 2006, Clinical science.

[17]  R. Klein,et al.  The prevalence and risk factors of retinal microvascular abnormalities in older persons: The Cardiovascular Health Study. , 2003, Ophthalmology.

[18]  R. Klein,et al.  Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. , 2002, JAMA.

[19]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[20]  A. Hofman,et al.  Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. , 2004, Investigative ophthalmology & visual science.

[21]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. , 2006, Current opinion in cardiology.

[22]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[23]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[24]  P. Mitchell,et al.  Cardiovascular risk factors and retinal microvascular signs in an adult Japanese population: the Funagata Study. , 2006, Ophthalmology.

[25]  F. Magrini,et al.  Prevalence of Left Ventricular Hypertrophy and Carotid Thickening in a Large Selected Hypertensive Population: Impact of Different Echocardiographic and Ultrasonographic Diagnostic Criteria , 2001, Blood pressure.

[26]  Tien Yin Wong,et al.  Retinal Arteriolar Diameter and Risk for Hypertension , 2004, Annals of Internal Medicine.

[27]  G. Mancia,et al.  Age and target organ damage in essential hypertension: role of the metabolic syndrome. , 2007, American journal of hypertension.

[28]  D. Biarent.  International Liaison Committee on Resuscitation: 2005 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Paediatric Basic and advanced life support. , 2005 .

[29]  L. Hansson,et al.  Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment. , 1992, Blood pressure.

[30]  P Pignoli,et al.  Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. , 1986, Circulation.

[31]  H G SCHEIE,et al.  Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis. , 1953, A.M.A. archives of ophthalmology.

[32]  Donna K Arnett,et al.  Retinal arteriolar narrowing and left ventricular hypertrophy in African Americans. the Atherosclerosis Risk in Communities (ARIC) study. , 2008, American journal of hypertension.

[33]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[34]  R. Klein,et al.  Hypertensive Retinal Vessel Wall Signs in a General Older Population: The Blue Mountains Eye Study , 2003, Hypertension.